[HTML][HTML] ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer
Highlights•A virtual consensus on the management of EGFR-mutant NSCLC was organized
by the ESMO, including 34 experts from 18 countries.•The experts compiled …
by the ESMO, including 34 experts from 18 countries.•The experts compiled …
ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer
A Passaro, N Leighl, F Blackhall… - Annals of …, 2022 - mdanderson.elsevierpure.com
Abstract The European Society for Medical Oncology (ESMO) held a virtual consensus-
building process on epidermal growth factor receptor (EGFR)-mutant non-small-cell lung …
building process on epidermal growth factor receptor (EGFR)-mutant non-small-cell lung …
ESMO expert consensus statements on the management of EGFR mutant Non-Small Cell Lung Cancer
A Passaro, N Leighl, F Blackhall, S Popat, K Kerr… - 2022 - christie.openrepository.com
The European Society for Medical Oncology (ESMO) held a virtual consensus-building
process on EGFR mutant non-small cell lung cancer (NSCLC) in 2021. The consensus …
process on EGFR mutant non-small cell lung cancer (NSCLC) in 2021. The consensus …
ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer.
A Passaro, N Leighl, F Blackhall, S Popat… - Annals of Oncology …, 2022 - europepmc.org
The European Society for Medical Oncology (ESMO) held a virtual consensus-building
process on epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancer in …
process on epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancer in …
ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer
A Passaro, N Leighl, F Blackhall… - Annals of …, 2022 - research.manchester.ac.uk
Abstract The European Society for Medical Oncology (ESMO) held a virtual consensus-
building process on epidermal growth factor receptor (EGFR)-mutant non-small-cell lung …
building process on epidermal growth factor receptor (EGFR)-mutant non-small-cell lung …
ESMO expert consensus statements on the management of EGFR mutant Non-Small Cell Lung Cancer
A Passaro, N Leighl, F Blackhall, S Popat… - ANNALS OF …, 2022 - air.unimi.it
The European Society for Medical Oncology (ESMO) held a virtual consensus-building
process on EGFR mutant non-small cell lung cancer (NSCLC) in 2021. The consensus …
process on EGFR mutant non-small cell lung cancer (NSCLC) in 2021. The consensus …
[引用][C] ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer
A Passaro, N Leighl, F Blackhall, S Popat, K Kerr… - Annals of …, 2022 - cir.nii.ac.jp
ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung
cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
[引用][C] ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer
A Passaro, N Leighl, F Blackhall… - Annals of …, 2022 - produccioncientifica.ucm.es
ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer
A Passaro, N Leighl, F Blackhall… - Annals of oncology …, 2022 - pubmed.ncbi.nlm.nih.gov
The European Society for Medical Oncology (ESMO) held a virtual consensus-building
process on epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancer in …
process on epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancer in …
[HTML][HTML] ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer
A Passaro, N Leighl, F Blackhall, S Popat… - Annals of …, 2022 - annalsofoncology.org
The European Society for Medical Oncology (ESMO) held a virtual consensus-building
process on epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancer in …
process on epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancer in …